Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory L Smoot

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Pancreas|May 13, 2016
Small Cell Carcinoma of the Pancreas: A Surgical DiseaseTommy Ivanics, John R Bergquist, Christopher R Shubert, et al.
Journal of Computer Assisted Tomography|December 1, 2017
How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy?Andreu F Costa, Amélie Tremblay St-Germain, Mohamed Abdolell, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Ayano Niibe, Jack W Sample, et al.
Surgical Endoscopy|March 23, 2024
The death of laparoscopyDavide Ferrari, Tommaso Violante, Marco Novelli, et al.
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 4, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Alejandro Lillo, Ayano Kabashima, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2Boris R A Blechacz, Rory L Smoot, Steven F Bronk, et al.
Gastrointestinal Endoscopy|May 31, 2003
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plicationsArnaldo B Feitoza, Christopher J Gostout, Elizabeth Rajan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 10, 2022
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesionsMatthew Aizpuru, Patrick Starlinger, David M Nagorney, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 5, 2021
Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysisMichael R Driedger, Thomas S Yamashita, Patrick Starlinger, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Pancreas|May 13, 2016
Small Cell Carcinoma of the Pancreas: A Surgical DiseaseTommy Ivanics, John R Bergquist, Christopher R Shubert, et al.
Journal of Computer Assisted Tomography|December 1, 2017
How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy?Andreu F Costa, Amélie Tremblay St-Germain, Mohamed Abdolell, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Ayano Niibe, Jack W Sample, et al.
Surgical Endoscopy|March 23, 2024
The death of laparoscopyDavide Ferrari, Tommaso Violante, Marco Novelli, et al.
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 4, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Alejandro Lillo, Ayano Kabashima, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2Boris R A Blechacz, Rory L Smoot, Steven F Bronk, et al.
Gastrointestinal Endoscopy|May 31, 2003
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plicationsArnaldo B Feitoza, Christopher J Gostout, Elizabeth Rajan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 10, 2022
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesionsMatthew Aizpuru, Patrick Starlinger, David M Nagorney, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 5, 2021
Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysisMichael R Driedger, Thomas S Yamashita, Patrick Starlinger, et al.
Pageof 16